Literature DB >> 15513918

The role of Plasmodium falciparum food vacuole plasmepsins.

Jun Liu1, Ilya Y Gluzman, Mark E Drew, Daniel E Goldberg.   

Abstract

Plasmepsins (PMs) are thought to have an important function in hemoglobin degradation in the malarial parasite Plasmodium falciparum and have generated interest as antimalarial drug targets. Four paralogous plasmepsins reside in the food vacuole of P. falciparum. Targeted gene disruption by double crossover homologous recombination has been employed to study food vacuole plasmepsin function in cultured parasites. Parasite clones with deletions in each of the individual PM I, PM II, and HAP genes as well as clones with a double PM IV/PM I disruption have been generated. All of these clones lack the corresponding PMs, are viable, and appear morphologically normal. PM II and PM IV/I disruptions have longer doubling times than the 3D7 parental line in rich RPMI medium. This appears to be because of a decreased level of productive progeny rather than an increased cell cycle time. In amino acid-limited medium, all four knockouts exhibit slower growth than the parental strain. Compared with 3D7, knock-out clone sensitivity to aspartic and cysteine protease inhibitors is changed minimally. These results suggest substantial functional redundancy and have important implications for the design of antimalarial drugs. The slow growth phenotype may explain why P. falciparum has maintained four plasmepsin genes with overlapping functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513918     DOI: 10.1074/jbc.M409740200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Authors:  T S Skinner-Adams; K T Andrews; L Melville; J McCarthy; D L Gardiner
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

2.  Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin.

Authors:  Sunil Parikh; Jun Liu; Puran Sijwali; Jiri Gut; Daniel E Goldberg; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.

Authors:  Katherine T Andrews; David P Fairlie; Praveen K Madala; John Ray; David M Wyatt; Petrina M Hilton; Lewis A Melville; Lynette Beattie; Donald L Gardiner; Robert C Reid; Martin J Stoermer; Tina Skinner-Adams; Colin Berry; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Disruption of the PfPK7 gene impairs schizogony and sporogony in the human malaria parasite Plasmodium falciparum.

Authors:  Dominique Dorin-Semblat; Audrey Sicard; Caroline Doerig; Lisa Ranford-Cartwright; Christian Doerig
Journal:  Eukaryot Cell       Date:  2007-12-14

5.  Plasmodium food vacuole plasmepsins are activated by falcipains.

Authors:  Mark E Drew; Ritu Banerjee; Eric W Uffman; Scott Gilbertson; Philip J Rosenthal; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

6.  Proteomic analysis of detergent-resistant membrane microdomains in trophozoite blood stage of the human malaria parasite Plasmodium falciparum.

Authors:  Xue Yan Yam; Cecilia Birago; Federica Fratini; Francesco Di Girolamo; Carla Raggi; Massimo Sargiacomo; Angela Bachi; Laurence Berry; Gamou Fall; Chiara Currà; Elisabetta Pizzi; Catherine Braun Breton; Marta Ponzi
Journal:  Mol Cell Proteomics       Date:  2013-09-17       Impact factor: 5.911

7.  Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

Authors:  Koushi Hidaka; Tooru Kimura; Adam J Ruben; Tsuyoshi Uemura; Mami Kamiya; Aiko Kiso; Tetsuya Okamoto; Yumi Tsuchiya; Yoshio Hayashi; Ernesto Freire; Yoshiaki Kiso
Journal:  Bioorg Med Chem       Date:  2008-10-10       Impact factor: 3.641

8.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

9.  An essential role for the Plasmodium Nek-2 Nima-related protein kinase in the sexual development of malaria parasites.

Authors:  Luc Reininger; Rita Tewari; Clare Fennell; Zoe Holland; Dean Goldring; Lisa Ranford-Cartwright; Oliver Billker; Christian Doerig
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

Review 10.  Malarial proteases and host cell egress: an 'emerging' cascade.

Authors:  Michael J Blackman
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.